$276.64
0.45% yesterday
NYSE, Oct 13, 10:00 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$276.64
+1.24 0.45% 1M
+48.60 21.31% 6M
+47.32 20.63% YTD
+59.79 27.57% 1Y
+96.84 53.86% 3Y
+109.77 65.78% 5Y
+181.20 189.85% 10Y
+235.61 574.25% 20Y
NYSE, Closing price Mon, Oct 13 2025
-1.24 0.45%

Key metrics

Basic
Market capitalization
$23.1b
Enterprise Value
$28.1b
Net debt
$5.0b
Cash
$647.3m
Shares outstanding
82.9m
Valuation (TTM | estimate)
P/E
30.6 | 16.5
P/S
1.7 | 1.6
EV/Sales
2.1 | 1.9
EV/FCF
22.3
P/B
2.7
Dividends
DPS
$2.88
Yield 1Y | 5Y
1.0% | 0.9%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
32.6% | 26.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$13.5b | $14.4b
EBITDA
$1.5b | $2.5b
EBIT
$1.2b | $2.0b
Net Income
$763.4m | $1.4b
Free Cash Flow
$1.3b
Growth (TTM | estimate)
Revenue
8.0% | 10.9%
EBITDA
9.8% | 78.6%
EBIT
8.8% | 78.9%
Net Income
69.8% | 86.7%
Free Cash Flow
48.1%
Margin (TTM | estimate)
Gross
28.1%
EBITDA
11.2% | 17.3%
EBIT
9.2%
Net
5.7% | 9.7%
Free Cash Flow
9.4%
Financial Health
Equity Ratio
43.8%
Return on Equity
9.3%
ROCE
8.0%
ROIC
6.0%
Debt/Equity
0.7
More
EPS
$9.1
FCF per Share
$15.2
Short interest
3.9%
Employees
65k
Rev per Employee
$200.0k
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Laboratory forecast:

24x Buy
83%
5x Hold
17%

Analyst Opinions

29 Analysts have issued a Laboratory forecast:

Buy
83%
Hold
17%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
13,484 13,484
8% 8%
100%
- Direct Costs 9,689 9,689
8% 8%
72%
3,795 3,795
9% 9%
28%
- Selling and Administrative Expenses 2,289 2,289
8% 8%
17%
- Research and Development Expense - -
-
-
1,506 1,506
10% 10%
11%
- Depreciation and Amortization 272 272
15% 15%
2%
EBIT (Operating Income) EBIT 1,234 1,234
9% 9%
9%
Net Profit 763 763
70% 70%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
PRNewsWire
5 days ago
BURLINGTON, N.C. , Oct. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
Neutral
PRNewsWire
14 days ago
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services BURLINGTON, N.C. , Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Roche to implement the company's FDA-cleared VENTANA® DP 600 and ...
Neutral
PRNewsWire
18 days ago
BURLINGTON, N.C. , Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025.
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 65,450
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today